Metabolic fates of 3-ethyl-5-phenylhydantoin (ethotoin, peganone) , 3-methyl-5-phenylhydantoin and 5-phenylhydantoin
Dudley, K.H.; Bius, D.L.; Butler, T.C.
Journal of Pharmacology and Experimental Therapeutics 175(1): 27-37
1970
ISSN/ISBN: 0022-3565 PMID: 5471450 Document Number: 18621
Document emailed within 1 workday
Related Documents
Hall, I.H.; Maguire, J.H.; Wong, O.T.; Day, P.A.; Alpin, R.S. 1987: A comparison of the S(+) and R(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents in rodents Biomedica Biochimica Acta 46(7): 623-634Lynch, J.; Montgomery, D.; Ventura, A.; Wilber, D.; Lucchesi, B.R. 1986: Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride Arzneimittel-Forschung 36(3): 475-481
Bius, D.L.; Yonekawa, W.D.; Kupferberg, H.J.; Cantor, F.; Dudley, K.H. 1980: Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 8(4): 223-229
Toyo-oka, T.; Kamishiro, T.; Gotoh, Y.; Fumino, H.; Masaki, T.; Hosoda, S. 1986: Temporary salvage of ischemic myocardium by the protease inhibitor bis[ethyl(2R,3R)-3-[(S)-methyl-1-[4-(2,3,4-trimethoxyphenyl-methyl) piperazin-1-ylcarbonyl]butyl-carbonyl]oxiran-2-carbo xylate]sulfate Arzneimittel-Forschung 36(4): 671-675
Saxena, R.; Iyer, R.N.; Anand, N.; Chatterjee, R.K.; Sen, A.B. 1970: 3-Ethyl-8-methyl-1,3,8-triazabicyclo(4,4,0)decan-2-one: a new antifilarial agent Journal of Pharmacy and Pharmacology 22(4): 306-307
Nalini, G.; Namasivayam, A. 1992: Influence of ethyl and methyl alcohol on rat brain histamine content Indian Journal of Physiology and Pharmacology 36(4): 285-286
Noggle, F.T.; DeRuiter, J.; Long, M.J. 1986: Spectrophotometric and liquid chromatographic identification of 3,4-methylenedioxyphenylisopropylamine and its N-methyl and N-ethyl homologs Journal - Association of Official Analytical Chemists 69(4): 681-686
Lipnicka, U.; Maczyński, M.; Artym, J.; Zimecki, M.ł 2009: Synthesis and immunomodulatory activites of new 5-hydrazino-3-methyl-4-isothiazolecarboxylic acid ethyl esters Acta Poloniae Pharmaceutica 66(5): 501-511
Monti, E.; Fornara, C.; Brembilla, E.; Dall'Oglio, A. 1984: Pharmacologic properties of etizolam (6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo 3,4-c thieno 2,3-e 1,4 diazepine) Minerva Psichiatrica 25(4): 269-274
Güthert, H.; Warzok, R. 1974: On the carcinogenic action of methyl- and ethyl-nitrosourea in rats after transplacental and postnatal application Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 118(2-3): 115-123
Altenkirch, H.; Wagner, H.M.; Stoltenburg-Didinger, G.; Steppat, R. 1982: Potentiation of hexacarbon-neurotoxicity by methyl-ethyl-ketone (MEK) and other substances: clinical and experimental aspects Neurobehavioral Toxicology and Teratology 4(6): 623-627
Chaudiere, J.; Clement, M.; Gerard, D.; Bourre, J.M. 1988: Brain alterations induced by vitamin e deficiency and intoxication with methyl ethyl ketone peroxide Neurotoxicology 9(2): 173-179
Bogomolova, Z.N.; Shtenberg, A.I. 1976: Concentration of mercuro-organic compounds (methyl- and ethyl derivatives) in several species of fish and sea products Voprosy Pitaniia 1: 50-53
Zhou, Y.J.; Zhang, W.N.; Lu, J.G.; Li, K.; Zhu, J. 1997: Synthesis and antifungal activities of 1-(2-[(substituted-phenyl) methyl]thio)-2-(2,4-difluorophenyl)ethyl-1H-1,2,4-triazoles Yao Xue Xue Bao 32(12): 902-907
Pfeifer, S.; Bornschein, I.; Gehrke, A. 1977: Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent Die Pharmazie 32(10): 587-592
Ivashchenko, A.V.; Kadieva, M.G.; Mit'kin, O.D.; Kravchenko, D.V.; Salimov, R.M.; Skrabelinskaia, E.I.; Fedotov, I.A.; Lavrovskiĭ, I.V. 2010: Toxicity of ethyl-3-(8-fluoro-2-methyl-2,3,4,5-tetrahydropyrido[4,3-b]indol-5-yl)-propionate dihydrochloride possessing antiallergic properties Eksperimental'naia i Klinicheskaia Farmakologiia 73(6): 33-35
Mosti, L.; Menozzi, G.; Schenone, P.; Dorigo, P.; Gaion, R.M.; Belluco, P. 1992: Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters Farmaco 47(4): 427-437
Shimizu, F.; Arakawa, M. 1975: Effect of 3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210 Gan 66(2): 149-154
Bagdasarian, N.A.; Khostikian, N.G.; Alikhanian, K.B.; Meliksetian, V.S.; Bagdasarian, M.G.; Stepanian, A.G.; Kukhtarova, A.M.; Mirzoian, N.R. 2014: Morphological changes in brain tissues of rat with local permanent ischemia model under the action of 2-methyl-6-ethyl-3-hydroxypyridine hemisuccinate Eksperimental'naia i Klinicheskaia Farmakologiia 77(12): 10-13
Mo, Z.; Jiao, X.; Su, H.; Zheng, H.; Weng, L. 1998: The estrogenic activities of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline(XW630)--a new compound with anti-osteoporosis activity Yao Xue Xue Bao 33(9): 645-649